5-amino-1mq 10mg reconstitution (10 mg Vial) Dosage Protocol 5-Amino-1MQ 10mg | Research Compound
Description
doi: 10.1111/j.1471-0528.2006.01062.x
6A, ivii)
Split option: Given the ~3.86.9 h half-life, 2.5 mg twice daily may sustain NNMT inhibition more evenly
While early and smaller trials showed promising fat-loss effects, the largest Phase IIb trial did not achieve statistical significance in humans for its primary endpoint of weight reduction, which led to the program being discontinued
Planning to change a lifestyle is part of the New Year
